Cargando…
Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
OBJECTIVES: To evaluate the effect of Mifepristone (25 mg) on symptomatic myoma in perimenopausal women. STUDY DESIGN: Open label clinical trial. MATERIALS AND METHODS: Ninety three perimenopausal women of age 35-50 years having symptomatic myoma were selected from Gynecology OPD and given 25 mg Mif...
Autores principales: | Seth, Shikha, Goel, Neeru, Singh, Ekta, Mathur, A. S., Gupta, Garima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702060/ https://www.ncbi.nlm.nih.gov/pubmed/23833529 http://dx.doi.org/10.4103/0976-7800.109630 |
Ejemplares similares
-
Low dose Mifepristone (100 mg) for medical termination of pregnancy
por: Seth, Shikha, et al.
Publicado: (2011) -
Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial
por: Carbonell, Josep Lluis, et al.
Publicado: (2013) -
Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
por: Esteve, Josep Lluis Carbonell, et al.
Publicado: (2013) -
A prospective interventional study to evaluate the effects of medical therapy (Mifepristone 25 mg) on the management of uterine fibroids
por: Gupta, Meeta, et al.
Publicado: (2020) -
The Treatment of Uterine Fibro-Myoma
por: Edgar, John
Publicado: (1902)